ISOINDOLINE COMPOUND, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND APPLICATION OF ISOINDOLINE COMPOUND
申请人:Shanghai Institute of Materia Medica,
Chinese Academy of Sciences
公开号:EP3896062A1
公开(公告)日:2021-10-20
The present invention relates to an isoindoline compound as represented by general formula (I) and used as a CRBN regulator, and a preparation method, a pharmaceutical composition, and an application of the isoindoline compound. Specifically, a class of polysubstituted isoindoline compound provided in the present invention, as a class of CRL4CRBN E3 ubiquitin ligase regulator having a novel structure, has good anti-tumor activity and immunoregulatory activity, and can be used for preparing drugs for treating diseases associated with a CRL4CRBN E3 ubiquitin ligase.
本发明涉及一种由通式(I)表示并用作CRBN调节剂的异吲哚啉化合物,以及该异吲哚啉化合物的制备方法、药物组合物和应用。具体而言,本发明提供的一类多取代异吲哚啉化合物,作为一类结构新颖的CRL4CRBN E3泛素连接酶调节剂,具有良好的抗肿瘤活性和免疫调节活性,可用于制备治疗与CRL4CRBN E3泛素连接酶相关疾病的药物。